April 26, 2018 | Houston Texas
Clinical Trials Xpress (CTX), an initiative of the University of Texas System, has been named by PAREXEL, the world's leading innovator of biopharmaceutical services, as a member of its Global Site Alliance Network. Through the network, CTX will work with PAREXEL to further clinical development of novel drug therapies through the facilitation of research.
Clinical Trials Xpress (CTX) is a UT System initiative launched in 2015 with support and seed funding from its Board of Regents, CTX represents an unmatched resource to support multisite clinical and translational research in Texas.
A single point-of-entry for industry sponsors and physician investigators to access streamlined, efficient administrative processes, dedicated central office resources and accelerated activation timelines to conduct their multi-site clinical trials in Texas.
NEWS AND EVENTS